Logo wahanariau.com
  2. Asklepios biopharmaceutical

Asklepios biopharmaceutical

Index
Globenewswire

First Participant Dosed in AskBio Phase 1/Phase 2 Gene Therapy Trial of AB-1009 for Late-Onset Pompe Disease (LOPD)

Senin, 11 Mei 2026 - 21:43:56 Wib
Globenewswire

AskBio Announces Completion of Enrollment in Phase 2 Clinical Trial of AB-1002 Investigational Gene Therapy for Heart Failure

Rabu, 01 April 2026 - 22:41:17 Wib
Globenewswire

First European Participants Randomized in AskBio Phase 2 Gene Therapy Trial of AB-1005 for Parkinson’s Disease

Selasa, 23 September 2025 - 02:40:18 Wib
Globenewswire

AskBio Advances Gene Therapy Clinical Trial for Limb-Girdle Muscular Dystrophy Type 2I/R9 with Dosing of First Participant in Second Cohort

Jumat, 07 Maret 2025 - 22:35:04 Wib
Globenewswire

AskBio Receives FDA Rare Pediatric Disease and Orphan-Drug Designations for AB-1003 for the Treatment of Limb-Girdle Muscular Dystrophy Type 2I/R9

Kamis, 07 November 2024 - 20:30:00 Wib
Globenewswire

AskBio Announces 11 Presentations at the European Society of Gene and Cell Therapy 31st Annual Meeting 2024

Kamis, 17 Oktober 2024 - 19:30:00 Wib